AI Insight
Researchers developed a metal-DNA biohybrid system that functions as an artificial photoDNAzyme capable of performing enantioselective catalysis. The system combines a metal complex with a DNA scaffold to create a synthetic enzyme that uses light as an energy source to drive chemical reactions while selectively producing one mirror-image form of a product over the other. This work demonstrates that DNA can serve as a chiral framework to control stereoselectivity in photocatalytic reactions, bridging inorganic chemistry and nucleic acid biology.
Why it matters
Enantioselective synthesis is critical in pharmaceutical development, where the two mirror-image forms of a molecule can have drastically different biological effects. This approach offers a potentially tunable and programmable platform for producing chiral compounds under mild, light-driven conditions, which could reduce reliance on costly or toxic traditional catalysts.
Source: A metal-DNA biohybrid as enantioselective artificial photoDNAzyme